Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
65,548,446
-
Shares change
-
+1,474,427
-
Total reported value, excl. options
-
$222,208,577
-
Value change
-
+$5,693,687
-
Put/Call ratio
-
63%
-
Number of buys
-
79
-
Number of sells
-
-44
-
Price
-
$3.39
Significant Holders of Xeris Biopharma Holdings, Inc. - COM (XERS) as of Q4 2024
175 filings reported holding XERS - Xeris Biopharma Holdings, Inc. - COM as of Q4 2024.
Xeris Biopharma Holdings, Inc. - COM (XERS) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65,548,446 shares
.
Largest 10 shareholders include BlackRock, Inc. (10,821,128 shares), VANGUARD GROUP INC (7,899,063 shares), GEODE CAPITAL MANAGEMENT, LLC (3,351,426 shares), STATE STREET CORP (3,341,874 shares), Rosalind Advisors, Inc. (3,104,995 shares), MORGAN STANLEY (2,877,516 shares), AIGH Capital Management LLC (2,574,846 shares), RENAISSANCE TECHNOLOGIES LLC (2,098,840 shares), CAXTON CORP (2,015,157 shares), and MILLENNIUM MANAGEMENT LLC (1,948,552 shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.